Outcome | Variables | OR1 | 95% CI1 | p-valor |
---|---|---|---|---|
Anxiety | ||||
Tumor type | ||||
Aggressive tumors | 1 | 0.800 | ||
Less aggressive tumors | 0.87 | 0.28, 2.57 | ||
Sex | ||||
Female | 1 | |||
Male | 0.68 | 0.21, 2.05 | 0.504 | |
Age | 0.98 | 0.94, 1.03 | 0.515 | |
Domains of EORTC-C30* | ||||
Overall Performance | 0.84 | 0.68, 1.03 | 0.101 | |
Physical Function | 0.81 | 0.67, 0.98 | 0.034 | |
Total Function | 0.81 | 0.69, 0.94 | 0.007 | |
Cognitive Function | 1.18 | 0.96, 1.47 | 0.120 | |
Emotional Function | 1.55 | 1.24, 2.04 | < 0.001 | |
Social role | 1.13 | 0.95, 1.35 | 0.158 | |
Financial difficulty | 1.14 | 0.97, 1.34 | 0.107 | |
Symptoms | ||||
Dyspnea | 1.06 | 0.88, 1.26 | 0.476 | |
Pain | 1.10 | 0.95, 1.29 | 0.213 | |
Fatigue | 1.11 | 0.93, 1.32 | 0.245 | |
Insomnia | 1.08 | 0.94, 1.25 | 0.279 | |
Loss of appetite | 1.12 | 0.99, 1.28 | 0.076 | |
Nausea/Vomiting | 1.08 | 0.92, 1.26 | 0.348 | |
Constipation | 1.07 | 0.93, 1.23 | 0.320 | |
Diarrhea | 1.05 | 0.86, 1.27 | 0.590 | |
Depression | Tumor type | |||
More aggressive tumors | 1 | 0.681 | ||
Less aggressive tumors | 0.82 | 0.31, 2.13 | ||
Sex | ||||
Female | 1 | 0.844 | ||
Male | 0.91 | 0.34, 2.38 | ||
Age | 1.00 | 0.96, 1.05 | 0.882 | |
Domains of EORTC-C30* | ||||
Overall Performance | 0.80 | 0.64, 0.97 | 0.033 | |
Physical Function | 0.81 | 0.67, 0.96 | 0.022 | |
Total Function | 0.82 | 0.71, 0.94 | 0.007 | |
Cognitive Function | 1.22 | 1.01, 1.51 | 0.046 | |
Emotional Function | 1.32 | 1.09, 1.64 | 0.007 | |
Social role | 1.19 | 1.01, 1.42 | 0.049 | |
Financial difficulty | 1.10 | 0.96, 1.27 | 0.190 | |
Symptoms | ||||
Dyspnea | 0.99 | 0.84, 1.17 | 0.937 | |
Pain | 1.09 | 0.95, 1.25 | 0.223 | |
Fatigue | 1.20 | 1.02, 1.43 | 0.030 | |
Insomnia | 1.00 | 0.88, 1.14 | 0.941 | |
Appetite loss | 1.06 | 0.95, 1.19 | 0.274 | |
Nausea/Vomiting | 1.08 | 0.94, 1.26 | 0.273 | |
Constipation | 1.04 | 0.92, 1.19 | 0.510 | |
Diarrhea | 1.12 | 0.93, 1.36 | 0.244 | |
Depression or anxiety | Tumor type | |||
More aggressive tumors | 1 | 0.259 | ||
Less aggressive tumors | 0.58 | 0.22, 1.50 | ||
Sex | ||||
Female | 1 | 0.696 | ||
Male | 0.83 | 0.31, 2.16 | ||
Age | 1.00 | 0.96, 1.04 | 0.954 | |
Domains of EORTC-C30* | ||||
Overall Performance | 0.76 | 0.60, 0.94 | 0.016 | |
Physical Function | 0.79 | 0.65, 0.95 | 0.016 | |
Total Function | 0.82 | 0.70, 0.94 | 0.008 | |
Cognitive Function | 1.21 | 1.00, 1.51 | 0.061 | |
Emotional Function | 1.45 | 1.17, 1.87 | 0.002 | |
Social role | 1.17 | 0.99, 1.42 | 0.078 | |
Financial difficulty | 1.12 | 0.97, 1.30 | 0.144 | |
Symptoms | ||||
Dyspnea | 1.00 | 0.85, 1.19 | 0.969 | |
Pain | 1.13 | 0.98, 1.30 | 0.093 | |
Fatigue | 1.19 | 1.01, 1.41 | 0.043 | |
Insomnia | 1.04 | 0.92, 1.18 | 0.545 | |
Appetite loss | 1.12 | 1.00, 1.27 | 0.049 | |
Nausea/Vomiting | 1.21 | 1.04, 1.45 | 0.021 | |
Constipation | 1.03 | 0.91, 1.18 | 0.601 | |
Diarrhea | 1.15 | 0.96, 1.46 | 0.164 |